Live Analyst Rating Changes 24491 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Sarah James
CANT

Sarah James

Cantor Fitzgerald
Wall Street Analyst
★★☆☆☆
#2665
on 13Foresight · ranked by our own returns
46%
Success Rate
+2.1%
Average Return
23 of 50 calls profitable · -5.7% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 46% of Sarah James's ratings turned a profit when each position was held for 1 year — averaging +2.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

57 Buy 40 Hold 0 Sell
Sarah's Stock Coverage 32 ratings · 2026-08-14
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
SGRY
Surgery Partners
 Aug 10, 2026 BUY Strong Buy
+47.6% avg upside
18 analysts
$18.00
18.48% Upside
 -3.6% ·
PGNY
Progyny
 Aug 06, 2026 BUY Strong Buy
+25.8% avg upside
14 analysts
$31.00
19.80% Upside
 -12.5% ·
LFMD
LifeMD
 Aug 05, 2026 BUY Strong Buy
+199.2% avg upside
14 analysts
$15.00
333.59% Upside
 -8.2% ·
ACHC
Acadia Healthcare
 Jul 29, 2026 HOLD Strong Buy
+37.3% avg upside
17 analysts
$30.00
0.84% Downside
 +15.9% ·
TDOC
Teladoc
 Jul 29, 2026 BUY Buy
+315.9% avg upside
38 analysts
$10.00
43.64% Upside
 -25.3% ·
UHS
Universal Health
 Jul 28, 2026 HOLD Buy
+15.0% avg upside
22 analysts
$194.00
13.29% Upside
 +2.6% ·
NPCE
NeuroPace
 Jul 28, 2026 BUY Strong Buy
+24.9% avg upside
13 analysts
$21.00
44.71% Upside
 -5.2% ·
CNC
Centene
 Jul 28, 2026 BUY Buy
+8.7% avg upside
29 analysts
$75.00
13.65% Upside
 +4.8% ·
MOH
Molina Healthcare
 Jul 23, 2026 HOLD Buy
+15.7% avg upside
26 analysts
$209.00
1.57% Upside
 +5.7% ·
THC
Tenet Healthcare
 Jul 23, 2026 BUY Strong Buy
-11.0% avg upside
27 analysts
$245.00
8.27% Downside
 +30.6% ·
HCA
HCA Healthcare
 Jul 14, 2026 BUY Buy
-0.7% avg upside
36 analysts
$525.00
27.44% Upside
 +11.7% ·
HUM
Humana
 Jul 07, 2026 HOLD Buy
+9.4% avg upside
34 analysts
$300.00
21.99% Downside
 -2.5% ·
ELV
Elevance Health
 Jul 07, 2026 BUY Strong Buy
+13.3% avg upside
33 analysts
$450.00
13.00% Upside
 -4.4% ·
CVS
CVS Health
 Jul 07, 2026 BUY Strong Buy
+11.5% avg upside
39 analysts
$110.00
15.81% Upside
 -7.0% ·
HCAT
Health Catalyst
 May 08, 2026 HOLD Buy
+218.0% avg upside
15 analysts
$3.00
71.34% Upside
 +23.7% ·
DCGO
DocGo
 May 08, 2026 BUY Buy
+317.5% avg upside
7 analysts
$3.00
359.23% Upside
 +14.0% ·
CI
Cigna
 Apr 30, 2026 BUY Strong Buy
+24.9% avg upside
29 analysts
$340.00
22.41% Upside
 -2.8% ·
NNOX
Nano-X Imaging
 Apr 20, 2026 BUY Strong Buy
+836.8% avg upside
7 analysts
$7.00
610.57% Upside
 -50.8% ·
NYXH
Nyxoah
 Mar 22, 2026 BUY Strong Buy
+793.7% avg upside
12 analysts
$11.00
596.19% Upside
 -53.5% ·
CVRX
CVRx
 Feb 15, 2026 BUY Buy
+155.1% avg upside
9 analysts
$13.00
342.21% Upside
 -38.0% ·
MDXG
MiMedx Group
 Feb 15, 2026 BUY Strong Buy
+154.3% avg upside
17 analysts
$8.00
90.52% Upside
 -18.6% ·
UNH
UnitedHealth
 Jan 28, 2026 BUY Strong Buy
+14.1% avg upside
36 analysts
$440.00
10.18% Upside
 +37.6% ·
ACAD
ACADIA Pharmaceuticals
 Jun 13, 2025 BUY Strong Buy
+28.3% avg upside
43 analysts
$28.00
1.39% Downside
 -2.9% ·
INNV
InnovAge Holding
 Sep 15, 2022 HOLD Sell
-31.1% avg upside
12 analysts
$5.00
53.02% Downside
 +48.2% ·
AVAH
Aveanna Healthcare Holdings
 Aug 19, 2022 BUY Buy
-14.2% avg upside
18 analysts
$5.00
55.78% Downside
 -14.4% ·
DVA
DaVita
 Aug 16, 2022 HOLD Buy
-4.5% avg upside
17 analysts
$103.00
42.57% Downside
 +12.2% ·
ASTH
Astrana Health
 Aug 05, 2022 HOLD Strong Buy
+56.3% avg upside
16 analysts
$57.00
50.80% Upside
 -30.8% ·
EHC
Encompass Health
 Nov 23, 2020 BUY Strong Buy
-9.0% avg upside
22 analysts
$76.33
38.31% Downside
 -19.8% ·
SLQT
SelectQuote
 Jun 15, 2020 BUY Buy
+973.0% avg upside
16 analysts
$32.00
4381.72% Upside
 · ·
HSIC
Henry Schein
 Nov 11, 2019 BUY Buy
+0.6% avg upside
25 analysts
$80.00
11.18% Downside
 -5.7% ·
CYH
Community Health
 Aug 07, 2019 SELL Sell
+39.8% avg upside
18 analysts
$3.00
1.04% Upside
 -130.8% ·
ISRG
Intuitive Surgical
 Oct 19, 2017 HOLD Strong Buy
+19.8% avg upside
36 analysts
$290.00
27.69% Downside
 +41.1% ·
🔒 27 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Sarah James — Frequently Asked Questions
How accurate are Sarah James's stock ratings?
Based on the calls 13Foresight could measure, about 46% of Sarah's ratings were profitable over a one-year hold, with an average return of +1.8% per rating, or -5.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Sarah ranked on 13Foresight?
Sarah James is currently ranked #2665 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Sarah cover?
Sarah most recently has ratings on SGRY, PGNY, LFMD, ACHC, TDOC, UHS, NPCE, CNC, MOH, THC, HCA, HUM and 20 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.